45 Students will Travel to SLAS2013 Through the SLAS Tony B. Academic Travel Awards Program
News Oct 26, 2012
Through the SLAS Tony B. Academic Travel Awards program, each will receive roundtrip travel (coach airfare or mileage reimbursement), shared hotel accommodations and full conference registration. Winners were determined by a panel of judges who conducted comprehensive evaluations of student abstract proposals and made selections based on scientific merit.
“SLAS invests $50,000 in this important annual program. The Tony B. Awards reflect the heart of the SLAS mission by encouraging the next generation of scientific thought leaders to explore the future of laboratory science and technology,” says SLAS President Dave Dorsett.
The Tony B. Academic Travel Awards honor the late Tony Beugelsdijk, Ph.D., an inspirational and iconic leader in the field of laboratory science and technology. Tony Beugelsdijk served at the forefront of this discipline, guiding its early stages of creation and development and making an extraordinary impact on the SLAS community.
Integrated Lead Discovery: An Evolving ToolboxNews
A new SLAS Discovery review article offers an informative guide to the established and emerging tools available for early drug discovery and screening, and provides illustrative scenarios demonstrating considerations that drive decisions on choice of lead discovery tactics.READ MORE
New Ovarian Cancer TargetNews
Researchers have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. This new study opens a potential avenue for treating ovarian cancer. Since Calcitriol is an FDA-approved drug, no additional research is needed before the drug can advance to human clinical trials for ovarian cancer.READ MORE
Novel Microplate 3D Bioprinting Platform for Engineering Muscle and Tendon TissuesNews
There is a strong need for medication that treats age-related degenerative muscle and tendon diseases. A critical bottleneck in the discovery and development of novel drugs for skeletal muscle is the lack of efficient and robust functional in vitro assays for compound screening. Researchers describe the development of a novel screening platform with automated production of 3D muscle- and tendon–like tissues using 3D bioprinting.READ MORE
Comments | 0 ADD COMMENT
10th Annual Congress on Drug Formulation & Analytical Techniques
Sep 03 - Sep 04, 2018